Page 197 - Color Atlas of Biochemistry
P. 197

188       Metabolism



             Purine and pyrimidine biosynthesis               (1b) and then converted into dihydroorotate
                                                              by closure of the ring (1c). In mammals, steps
             The bases occurring in nucleic acids are de-     1a to 1c take place in the cytoplasm, and are
             rivatives of the aromatic heterocyclic com-      catalyzed by a single multifunctional enzyme.
             pounds purine and pyrimidine (see p. 80).        In the next step (1d), dihydroorotate is oxi-
             The biosynthesis of these molecules is com-      dized to orotate by an FMN-dependent dehy-
             plex, but is vital for almost all cells. The syn-  drogenase. Orotate is then linked with phos-
             thesis of the nucleobases is illustrated here    phoribosyl diphosphate (PRPP) to form the
             schematically. Complete reaction schemes         nucleotide    orotidine   5 -monophosphate
             are given on pp. 417 and 418.                    (OMP). Finally, decarboxylation yields uridine
                                                              5 -monophosphate (UMP).
                                                                 Purine biosynthesis starts with PRPP (the
             A. Components of nucleobases
                                                              names of the individual intermediates are
             The pyrimidine ring is made up of three com-     givenon p. 417). Formationof the ring starts
             ponents: the nitrogen atom N-1 and carbons       with transfer of an amino group, from which
             C-4 to C-6 are derived from aspartate, carbon    the later N-9 is derived (2a). Glycine and a
                                   -
             C-2 comes from HCO 3 ,and thesecondnitro-        formyl group from N  10- formyl-THF then sup-
             gen(N-3) is takenfrom the amide group of         ply the remaining atoms of the five-mem-
             glutamine.                                       bered ring (2b, 2c). Before the five-membered
                The synthesis of the purine ring is more      ring is closed (in step 2f), atoms N-3 and C-6
             complex. The only major component is gly-        of the later six-membered ring are attached
             cine, which donates C-4 and C-5, as well as N-   (2d, 2e). Synthesis of the ring then continues
             7. All of the other atoms in the ring are in-    with N-1 and C-2 (2g, 2i). In the final step (2j),
             corporated individually. C-6 comes from          the six-membered ring is closed, and inosine
                   –
             HCO 3 .Amide groups from glutamine provide       5 -monophosphate arises. However, the IMP
             the atoms N-3 and N-9. The amino group           formed does not accumulate, but is rapidly
             donor for the inclusion of N-1 is aspartate,     converted into AMP and GMP. These reactions
             which is converted into fumarate in the proc-    and the synthesis of the other nucleotides are
             ess, in thesameway as in the urea cycle (see     discussed on p. 190.
             p. 182). Finally, the carbon atoms C-2 and C-8
                                                        10
             are derived from formyl groups in N -            Further information
             formyl-tetrahydrofolate (see p. 108).
                                                              The   regulation    of  bacterial   aspartate
                                                              carbamoyltransferase by ATP and CTP has
             B. Pyrimidine and purine synthesis
                                                              been particularly well studied, and is dis-
             The major intermediates in the biosynthesis      cussed on p. 116. In animals, in contrast to
             of   nucleic   acid  components     are   the    prokaryotes, it is not ACTase but carbamoyl-
             mononucleotides     uridine   monophosphate      phosphate synthase that is the key enzyme in
             (UMP) in the pyrimidine series and inosine       pyrimidine synthesis. It is activated by ATP
             monophosphate (IMP, base: hypoxanthine) in       and PRPP and inhibited by UTP.
             the purines. The synthetic pathways for pyri-       The biosynthesis of the purines is also
             midines and purines are fundamentally dif-       regulated by feedback inhibition. ADP and
             ferent. For the pyrimidines, the pyrimidine      GDP inhibit the formation of PRRPP from ri-
             ring is first constructed and then linked to     bose-5 -phosphate. Similarly, step 2a is in-
             ribose 5 -phosphate to form a nucleotide. By     hibitedbyAMP andGMP.
             contrast, synthesis of the purines starts di-
             rectly from ribose 5 -phosphate. The ring is
             then built up step by step on this carrier mol-
             ecule.
                The precursors for the synthesis of the
             pyrimidine ring are carbamoyl phosphate,
                                                     –
             which arises from glutamate and HCO 3 (1a)
             and the amino acid aspartate. These two com-
             ponents are linked to N-carbamoyl aspartate


           Koolman, Color Atlas of Biochemistry, 2nd edition © 2005 Thieme
           All rights reserved. Usage subject to terms and conditions of license.
   192   193   194   195   196   197   198   199   200   201   202